Skip to main content
. Author manuscript; available in PMC: 2023 May 18.
Published in final edited form as: Mol Psychiatry. 2020 Jun 2;26(10):6023–6037. doi: 10.1038/s41380-020-0797-2

Table 4:

Comparisons of NGF metabolic pathway proteins in frontal cortex between individuals classified LA-NCI (n = 43), HA-NCI (n = 16), MCI (n = 20), and AD (n = 19).

Species LA-NCI vs HA-NCI LA-NCI vs. MCI LA-NCI vs AD Overall
NGF mRNA n.s. n.s. n.s. df=3,95; H = 2.4; p > 0.05
NGF protein rs = 8.842, p = 0.06 rs = 15.73, p < 0.01 rs = 17.14, p < 0.01 df = 2,52; H = 14.38; p < 0.01
proNGF 27 kDa t=4.095, p < 0.001 t = 7.058, p < 0.001 t = 4.984 p < 0.001 df = 3,95; F = 19.96; p < 0.0001
proNGF 41 kDa t = 3.795, p < 0.001 t = 5.399, p < 0.001 t = 4.035, p < 0.001 df = 3,95; F = 12.68; p < 0.0001
Plasminogen mRNA n.s n.s n.s df = 3,95; H = 0.87; p > 0.05
Plasminogen protein t = 2.605, p < 0.05 t = 4.035, p < 0.001 t = 3.070 p < 0.01 df = 3,95; F = 26.80; p < 0.0001
tPA mRNA rs = 22.37, p < 0.05 n.s n.s df = 3,95; H = 7.652; p = 0.05
tPA protein rs = 23.46, p < 0.05 n.s n.s df = 3,95; H = 8.754, p < 0.05
Neuroserpin mRNA n.s rs = 30.91, p < 0.001 rs = 22.26, p < 0.05 df = 3,95; H = 29.23; p < 0.0001
Neuroserpin protein n.s rs = −34.41, p < 0.001 rs = −33.39 p < 0.001 df = 3,95; H = 30.18; p < 0.0001
MMP9 mRNA n.s rs = 26.67, p < 0.001 rs = 28.63, p < 0.001 df = 3,95; H = 25.44; p < 0.0001
MMP9 activity n.s rs = 27.55, p < 0.001 rs = 33.91 p < 0.001 df = 3,95; H = 29.33; p < 0.0001
proMMP9 activity n.s rs = 27.55, p < 0.001 t = 33.91 p < 0.001 df = 3,95; H = 29.33; p < 0.0001
TIMP1 mRNA n.s rs = 18.90, p < 0.05 rs = 26.40, p < 0.01 df = 3,95; H = 15.03; p < 0.01

Results of ANOVA/Kruskal-Wallis comparison and Bonferroni/Dunn’s post-hoc tests are reported.